EGPI Firecreek, Inc./ US2684874025 /
10/05/2024 15:30:00 | Chg. - | Volume | Bid- | Demandez à- | Haut | Bas |
---|---|---|---|---|---|---|
0.0000USD | - | 530,000 Chiffrre d'affaires: .5300 |
-Bid taille: - | -Ask la taille: - | 0.0000 | 0.0000 |
GlobeNewswire
14:30
Zhibao Technology Inc. Announces Closing of Underwriters’ Over-Allotment Option in Connection with I...
GlobeNewswire
14:30
Hudson Technologies to Attend 24th Annual B. Riley Securities Institutional Investor Conference
GlobeNewswire
14:30
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic C-Store Plans in Los Angeles with 7-Eleven
GlobeNewswire
14:30
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights fo...
GlobeNewswire
14:30
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the A...
GlobeNewswire
14:30
Reliance Global Group Announces Game-Changing Acquisition of Spetner Associates; Projected to Double...
GlobeNewswire
14:30
ALERUS FINANCIAL CORPORATION AND HMN FINANCIAL, INC. JOINTLY ANNOUNCE STRATEGIC TRANSACTION
GlobeNewswire
14:30
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
14:30
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
GlobeNewswire
14:30
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
14:30
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Tria...
GlobeNewswire
14:30
Leaders in Data Strategy Gather at Qlik Connect 2024 to Showcase AI Innovation and Results
GlobeNewswire
14:30
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page